BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: You L, Wu W, Wang X, Fang L, Adam V, Nepovimova E, Wu Q, Kuca K. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev 2021;41:1622-43. [PMID: 33305856 DOI: 10.1002/med.21771] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 35.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiang H, Yang R, Tu J, Xi Y, Yang S, Lv L, Zhai X, Zhu Y, Dong D, Tao X. Metabolic reprogramming of immune cells in pancreatic cancer progression. Biomedicine & Pharmacotherapy 2023;157:113992. [DOI: 10.1016/j.biopha.2022.113992] [Reference Citation Analysis]
2 Li X, Hu Y, Xie Y, Lu R, Li Q, Tao H, Chen S. Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09296-z] [Reference Citation Analysis]
3 Luo S, Jiang Y, Anfu Zheng, Zhao Y, Wu X, Li M, Du F, Chen Y, Deng S, Chen M, Li W, Li X, Gu L, Sun Y, Xiao Z, Shen J. Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1064661] [Reference Citation Analysis]
4 Lei L, Huang D, Gao H, He B, Cao J, Peppas NA. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy. Sci Adv 2022;8. [DOI: 10.1126/sciadv.adc8738] [Reference Citation Analysis]
5 Musick M, Yu X. Immunotherapeutic effects of intratumorally injected Zymosan-Adenovirus conjugates encoding constant active IRF3 in a melanoma mouse model. Immunol Res 2022. [DOI: 10.1007/s12026-022-09336-2] [Reference Citation Analysis]
6 Chen Z, Yue Z, Yang K, Li S. Nanomaterials: small particles show huge possibilities for cancer immunotherapy. J Nanobiotechnol 2022;20:484. [DOI: 10.1186/s12951-022-01692-3] [Reference Citation Analysis]
7 Feng Z, Fan Y, Xie J, Liu S, Duan C, Wang Q, Ye Y, Yin W. HIF-1α promotes the expression of syndecan-1 and inhibits the NLRP3 inflammasome pathway in vascular endothelial cells under hemorrhagic shock. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.10.102] [Reference Citation Analysis]
8 Zhang Z, Hu Y, Chen Y, Chen Z, Zhu Y, Chen M, Xia J, Sun Y, Xu W. Immunometabolism in the tumor microenvironment and its related research progress. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1024789] [Reference Citation Analysis]
9 Liu Z, Xiang Y, Zheng Y, Kang X. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology. Front Immunol 2022;13:1027124. [DOI: 10.3389/fimmu.2022.1027124] [Reference Citation Analysis]
10 Liu C, Liu L. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma. Front Genet 2022;13:1037716. [DOI: 10.3389/fgene.2022.1037716] [Reference Citation Analysis]
11 Shao X, Hua S, Feng T, Ocansey DKW, Yin L. Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion. IJMS 2022;23:11789. [DOI: 10.3390/ijms231911789] [Reference Citation Analysis]
12 Tao J, Miao R, Liu G, Qiu X, Yang B, Tan X, Liu L, Long J, Tang W, Jing W. Spatiotemporal correlation between HIF-1α and bone regeneration. FASEB J 2022;36:e22520. [PMID: 36065633 DOI: 10.1096/fj.202200329RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Du X, Yang X, Zhang Y, Gao S, Liu S, Ji J, Zhai G. Transdermal delivery system based on heparin-modified graphene oxide for deep transportation, tumor microenvironment regulation, and immune activation. Nano Today 2022;46:101565. [DOI: 10.1016/j.nantod.2022.101565] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Taghizadeh-hesary F, Akbari H, Bahadori M, Behnam B. Targeted Anti-Mitochondrial Therapy: The Future of Oncology. Genes 2022;13:1728. [DOI: 10.3390/genes13101728] [Reference Citation Analysis]
15 Maccio U, Mihic A, Lenggenhager D, Kolm I, Mittmann C, Heikenwälder M, Lorentzen A, Mihic-probst D. Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance. IJMS 2022;23:10745. [DOI: 10.3390/ijms231810745] [Reference Citation Analysis]
16 You L, Wang X, Wu W, Nepovimova E, Wu Q, Kuca K. HIF-1α inhibits T-2 toxin-mediated "immune evasion" process by negatively regulating PD-1/PD-L1. Toxicology 2022;480:153324. [PMID: 36115646 DOI: 10.1016/j.tox.2022.153324] [Reference Citation Analysis]
17 Huang C, Zhu J, Li Y, Xu J, Chen R, Guo M, Qian X, Li T, Tian Z, jin H. NF-κB1 p50 Stabilizes HIF-1α Protein through Suppression of ATG7-dependent Autophagy.. [DOI: 10.21203/rs.3.rs-1976707/v1] [Reference Citation Analysis]
18 Huang Q, Qiao Lv, Jiang L, Chen Q, Zhang K. Recent progress of biocompatible carbon dots in hypoxia-related fields. J Biomater Appl 2022;:8853282221125313. [PMID: 36083209 DOI: 10.1177/08853282221125313] [Reference Citation Analysis]
19 Reimche I, Yu H, Ariantari NP, Liu Z, Merkens K, Rotfuß S, Peter K, Jungwirth U, Bauer N, Kiefer F, Neudörfl J, Schmalz H, Proksch P, Teusch N. Phenanthroindolizidine Alkaloids Isolated from Tylophora ovata as Potent Inhibitors of Inflammation, Spheroid Growth, and Invasion of Triple-Negative Breast Cancer. IJMS 2022;23:10319. [DOI: 10.3390/ijms231810319] [Reference Citation Analysis]
20 Rasihashemi SZ, Sahrai H, Rezazadeh-Gavgani E, Yazdani Y, Khalaji A, Lotfinejad P. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment. Med Oncol 2022;39:183. [PMID: 36071295 DOI: 10.1007/s12032-022-01781-1] [Reference Citation Analysis]
21 Yan W, Lang T, Yuan W, Yin Q, Li Y. Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy. Acta Pharmacol Sin. [DOI: 10.1038/s41401-022-00976-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yong L, Tang S, Yu H, Zhang H, Zhang Y, Wan Y, Cai F. The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer. Front Oncol 2022;12:964934. [DOI: 10.3389/fonc.2022.964934] [Reference Citation Analysis]
23 Lv H, Liu H, Sun T, Wang H, Zhang X, Xu W. Exosome derived from stem cell: A promising therapeutics for wound healing. Front Pharmacol 2022;13:957771. [DOI: 10.3389/fphar.2022.957771] [Reference Citation Analysis]
24 Liu YJ, Li JP, Li HR, Zeng SH, Chen YG, Han M, Ye QW, Zhou JY, Liu SL, Zou X. An analysis of the significance of the Tre2/Bub2/CDC 16 (TBC) domain protein family 8 in colorectal cancer. Sci Rep 2022;12:13245. [PMID: 35918393 DOI: 10.1038/s41598-022-15629-1] [Reference Citation Analysis]
25 Xiong Y, Xu S, Fu B, Tang W, Zaky MY, Tian R, Yao R, Zhang S, Zhao Q, Nian W, Lin X, Wu H. Vitamin C-induced competitive binding of HIF-1α and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation. Food Chem Toxicol 2022;168:113321. [PMID: 35931247 DOI: 10.1016/j.fct.2022.113321] [Reference Citation Analysis]
26 Li Y, Song J, Zhou P, Zhou J, Xie S. Targeting Undruggable Transcription Factors with PROTACs: Advances and Perspectives. J Med Chem 2022. [PMID: 35881047 DOI: 10.1021/acs.jmedchem.2c00691] [Reference Citation Analysis]
27 Gallez B. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Front Pharmacol 2022;13:853568. [DOI: 10.3389/fphar.2022.853568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tian Y, Bai F, Zhang D, Isaguliants M. HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/1246267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhong X, He X, Wang Y, Hu Z, Yu D, Huang H, Zhao S, Wei P, Li D, Zhang X. A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer. Journal of Immunology Research 2022;2022:1-23. [DOI: 10.1155/2022/9935705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tian Y, Sang W, Tian H, Xie L, Wang G, Zhang Z, Li W, Dai Y. A Two‐Step Flexible Ultrasound Strategy to Enhance the Tumor Radiotherapy via Metal–Phenolic Network Nanoplatform. Adv Funct Materials. [DOI: 10.1002/adfm.202205690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wu L, Liu J, Wang S, Bai M, Wu M, Gao Z, Li J, Yu J, Liu J, Meng X. Negative Correlation Between 18F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer. Front Endocrinol 2022;13:913631. [DOI: 10.3389/fendo.2022.913631] [Reference Citation Analysis]
32 Mortezaee K, Majidpoor J. NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives. Med Oncol 2022;39:131. [PMID: 35716327 DOI: 10.1007/s12032-022-01735-7] [Reference Citation Analysis]
33 Wang C, Tang Y, Ma H, Wei S, Hu X, Zhao L, Wang G. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Front Genet 2022;13:919389. [DOI: 10.3389/fgene.2022.919389] [Reference Citation Analysis]
34 Qin S, Li B, Ming H, Nice EC, Zou B, Huang C. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy. Biochim Biophys Acta Rev Cancer 2022;1877:188749. [PMID: 35716972 DOI: 10.1016/j.bbcan.2022.188749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Xu Y, Cao C, Zhu Z, Wang Y, Tan Y, Xu X. Novel Hypoxia-Associated Gene Signature Depicts Tumor Immune Microenvironment and Predicts Prognosis of Colon Cancer Patients. Front Genet 2022;13:901734. [DOI: 10.3389/fgene.2022.901734] [Reference Citation Analysis]
36 Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, Adam V. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol 2022;15:77. [PMID: 35659268 DOI: 10.1186/s13045-022-01292-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
37 Chen L, Huang J, Li X, Huang M, Zeng S, Zheng J, Peng S, Li S. Progress of Nanomaterials in Photodynamic Therapy Against Tumor. Front Bioeng Biotechnol 2022;10:920162. [DOI: 10.3389/fbioe.2022.920162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bai S, Chen L, Yan Y, Li R, Zhou Y, Wang X, Kang H, Feng Z, Li G, Zhou S, Drokow EK, Ren J. Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer. Front Immunol 2022;13:853352. [DOI: 10.3389/fimmu.2022.853352] [Reference Citation Analysis]
39 Kleibert M, Majka M, Łakomska K, Czystowska-kuźmicz M. Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma. JPM 2022;12:772. [DOI: 10.3390/jpm12050772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Smith PJ, McKeown SR, Patterson LH. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). IUBMB Life 2022. [PMID: 35499745 DOI: 10.1002/iub.2619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Jiang Z, Liu Y, Shi R, Feng X, Xu W, Zhuang X, Ding J, Chen X. Versatile Polymer-Initiating Biomineralization for Tumor Blockade Therapy. Adv Mater 2022;34:e2110094. [PMID: 35202501 DOI: 10.1002/adma.202110094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
42 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
43 Chen H, Chen X, Ping Z, Jiang X, Ge M, Ma J, Yu W. Promotion Effect of Angelica Sinensis Extract on Angiogenesis of Chicken Preovulatory Follicles in Vitro. Poultry Science 2022. [DOI: 10.1016/j.psj.2022.101938] [Reference Citation Analysis]
44 Abou Khouzam R, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, Terry S, Chouaib S. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? Front Immunol 2022;13:828875. [PMID: 35211123 DOI: 10.3389/fimmu.2022.828875] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
45 Yan J, Huang YJ, Huang QY, Liu PX, Wang CS. Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma. PeerJ 2022;10:e13201. [DOI: 10.7717/peerj.13201] [Reference Citation Analysis]
46 Kim MJ, Ku JM, Choi YJ, Lee SY, Hong SH, Kim HI, Shin YC, Ko SG. Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits Lung Cancer Growth through the Induction of Cell Death. Molecules 2022;27:2106. [PMID: 35408505 DOI: 10.3390/molecules27072106] [Reference Citation Analysis]
47 Pei H, Guo W, Peng Y, Xiong H, Chen Y. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective. Med Res Rev 2022. [PMID: 35312190 DOI: 10.1002/med.21886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
48 Bai S, Chen L, Yan Y, Wang X, Jiang A, Li R, Kang H, Feng Z, Li G, Ma W, Zhang J, Ren J. Identification of Hypoxia-Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma. Front Cell Dev Biol 2021;9:796156. [PMID: 35211477 DOI: 10.3389/fcell.2021.796156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Liu J, Peng X, Yang S, Li X, Huang M, Wei S, Zhang S, He G, Zheng H, Fan Q, Yang L, Li H. Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00816-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
50 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
51 Tian W, Lei N, Zhou J, Chen M, Guo R, Qin B, Li Y, Chang L. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis 2022;13:64. [PMID: 35042862 DOI: 10.1038/s41419-022-04510-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
52 Li J, Zhang G, Liu CG, Xiang X, Le MTN, Sethi G, Wang L, Goh BC, Ma Z. The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy. Theranostics 2022;12:87-104. [PMID: 34987636 DOI: 10.7150/thno.64096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
53 Tian T, Han J, Huang J, Li S, Pang H. Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer. Front Oncol 2021;11:784777. [PMID: 34988020 DOI: 10.3389/fonc.2021.784777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2022. [DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
55 Wei C, Ma Y, Wang F, Liao Y, Chen Y, Zhao B, Zhao Q, Wang D, Tang D. Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition. Clin Med Insights Oncol 2022;16:117955492211207. [DOI: 10.1177/11795549221120708] [Reference Citation Analysis]
56 Pei P, Shen W, Zhang Y, Zhang Y, Qi Z, Zhou H, Liu T, Sun L, Yang K. Radioactive nano-oxygen generator enhance anti-tumor radio-immunotherapy by regulating tumor microenvironment and reducing proliferation. Biomaterials 2022;280:121326. [PMID: 34953386 DOI: 10.1016/j.biomaterials.2021.121326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
57 Zhuang H, Wang S, Chen B, Zhang Z, Ma Z, Li Z, Liu C, Zhou Z, Gong Y, Huang S, Hou B, Chen Y, Zhang C. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Front Immunol 2021;12:790661. [PMID: 34925373 DOI: 10.3389/fimmu.2021.790661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhan B, Dong X, Yuan Y, Gong Z, Li B. hZIP1 Inhibits Progression of Clear Cell Renal Cell Carcinoma by Suppressing NF-kB/HIF-1α Pathway. Front Oncol 2021;11:759818. [PMID: 34926261 DOI: 10.3389/fonc.2021.759818] [Reference Citation Analysis]
59 Pansy K, Uhl B, Krstic J, Szmyra M, Fechter K, Santiso A, Thüminger L, Greinix H, Kargl J, Prochazka K, Feichtinger J, Deutsch AJ. Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. Int J Mol Sci 2021;22:13311. [PMID: 34948104 DOI: 10.3390/ijms222413311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
60 Jiang H, Li M, Du K, Ma C, Cheng Y, Wang S, Nie X, Fu C, He Y. Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction. Chin Med 2021;16:129. [PMID: 34857023 DOI: 10.1186/s13020-021-00539-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
61 Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C. Hypoxia: The Cornerstone of Glioblastoma. Int J Mol Sci 2021;22:12608. [PMID: 34830491 DOI: 10.3390/ijms222212608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
62 Zhang L, Zhang H, Xie J, Wang X. Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder. Int J Gen Med 2021;14:7983-93. [PMID: 34785941 DOI: 10.2147/IJGM.S336686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yuan H, Lu Y, Chan YT, Zhang C, Wang N, Feng Y. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. Cancers (Basel) 2021;13:5700. [PMID: 34830854 DOI: 10.3390/cancers13225700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Capitani N, Patrussi L, Baldari CT. Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment. Int J Mol Sci 2021;22:11221. [PMID: 34681881 DOI: 10.3390/ijms222011221] [Reference Citation Analysis]
65 Spirina L, Avgustinovich A, Afanas'ev S, Volkov M, Dobrodeev A, Cheremisina O, Kostromitsky D. PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation. Int J Mol Sci 2021;22:11176. [PMID: 34681840 DOI: 10.3390/ijms222011176] [Reference Citation Analysis]
66 Bailly C. Anticancer Targets and Signaling Pathways Activated by Britannin and Related Pseudoguaianolide Sesquiterpene Lactones. Biomedicines 2021;9:1325. [PMID: 34680439 DOI: 10.3390/biomedicines9101325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Janji B, Chouaib S. "Suffocating" tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy. Oncoimmunology 2021;10:1968611. [PMID: 34527430 DOI: 10.1080/2162402X.2021.1968611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Tan L, Cheng D, Wen J, Huang K, Zhang Q. Identification of prognostic hypoxia-related genes signature on the tumor microenvironment in esophageal cancer. Math Biosci Eng 2021;18:7743-58. [PMID: 34814273 DOI: 10.3934/mbe.2021384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Shao J, Zhang B, Kuai L, Li Q. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients. Bioengineered 2021;12:6186-200. [PMID: 34486476 DOI: 10.1080/21655979.2021.1973874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
70 Zhang L, Kuca K, You L, Zhao Y, Musilek K, Nepovimova E, Wu Q, Wu W, Adam V. Signal transducer and activator of transcription 3 signaling in tumor immune evasion. Pharmacol Ther 2021;:107969. [PMID: 34450232 DOI: 10.1016/j.pharmthera.2021.107969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
71 Yang X, Weng X, Yang Y, Zhang M, Xiu Y, Peng W, Liao X, Xu M, Sun Y, Liu X. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Aging (Albany NY) 2021;13:19486-509. [PMID: 34341184 DOI: 10.18632/aging.203360] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
72 Anduran E, Dubois LJ, Lambin P, Winum JY. Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert Opin Ther Pat 2021;:1-12. [PMID: 34241566 DOI: 10.1080/13543776.2021.1954617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
73 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
74 Feng Z, Qian H, Li K, Lou J, Wu Y, Peng C. Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:676291. [PMID: 34095229 DOI: 10.3389/fmolb.2021.676291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 He F, Xiao H, Cai Y, Zhang N. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer. Cell Commun Signal 2021;19:53. [PMID: 33980247 DOI: 10.1186/s12964-021-00734-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Zhang Y, Yang F, Peng X, Li X, Luo N, Zhu W, Fu M, Li Q, Hu G. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment. Front Cell Dev Biol 2021;9:665364. [PMID: 33959617 DOI: 10.3389/fcell.2021.665364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]